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ABSTRACT
Atypical inflammatory demyelinating syndromes are rare neurological diseases that differ from multiple sclerosis (MS), 
owing to unusual clinicoradiological and pathological findings, and poor responses to treatment. The distinction between 
them and the criteria for their diagnoses are poorly defined due to the lack of advanced research studies. Balo’s concentric 
sclerosis (BCS) and Schilder’s disease (SD) are two of these syndromes and can present as monophasic or in association 
with chronic MS. Both variants are difficult to distinguish when they present in acute stages. We describe an autopsy case 
of middle-aged female with a chronic history of MS newly relapsed with atypical demyelinating lesions, which showed 
concurrent features of BCS and SD. We also describe the neuropathological findings, and discuss the overlapping features 
between these two variants. 
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CASE REPORT
A 45-year-old woman presented in another 
hospital with a history of generalized tonic clonic 
seizure and acute confusion. She was admitted to 
the intensive care unit for close observation. Her past 
medical history revealed that she had been diagnosed 
clinically with multiple sclerosis (MS) in 2005, and 
had shown a good response to various combinations 
of methylprednisolone, cyclophosphamide, and 
interferon. During the course of her illness, she had 
a history of multiple admissions to the hospital with 
several relapses between 2005 and 2006. Her disease 
settled in the remitting phase for 7 years. In this 
current admission, her medical condition deteriorated 
and she became unresponsive to the usual medical 
treatment. Brain magnetic resonance imaging (MRI) 
with gadolinium contrast showed space-occupying 
lesions in the right and left frontal white matter, with 
the left showing concentric rings with an onionskin 
pattern (Figure 1).
Blood chemistry revealed a normal blood count 
and normal renal and liver function. HIV anti-nuclear 
antibody, anti-dsDNA, rheumatoid factor, and 
ant i -phospho l ip id  ant ibody  were  negat i ve . 
Cerebrospinal fluid (CSF) analysis was negative 
for anti-aquaporin-4 (anti-AQP4) antibody with 
absent oligoclonal band immunoglobulin G (IgG). 
The concentration of very long-chain fatty acids 
was normal. The patient was treated with high-dose 
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methylprednisolone, after which her clinical symptoms 
did not improve. Unfortunately, she had a sudden 
cardiorespiratory arrest from which she could not be 
resuscitated. The family requested a general autopsy 
including the brain and spinal cord. The general 
autopsy revealed a pulmonary embolus as a cause of 
her death. The formalin-fixed brain and spinal cord 
were referred to our institution for neuropathological 
consultation.
NEUROPATHOLOGICAL ASSESSMENT
The fixed brain weight was 1226 g. The whole 
brain showed a very mild atrophy. The brain-cut 
protocol was performed. There were symmetrical areas 
of brown-gray discolorations of the centrum semiovale 
extending into the digitate white matter. These lesions 
were found in the anterior part of the right frontal 
lobe (Figure 2A), the dorsal part of the left frontal 
lobe (Figure 2B and 2C), and the parietal occipital 
regions. The left frontal lesion (measuring 2.3 × 3.3 cm) 
showed distinct arranged grossly viable laminae with 
a concentric globe.
The right frontal lesion showed clearly visible 
subcortical U-fiber (SCUF). The focal lesions in the 
parietal-occipital regions were partially cystic.
Sections from the left and right frontal lesions were 
examined using light and electron microscopy. We used 
different staining protocols on the sections taken from 
the right and left frontal lobes. Hematoxylin and eosin 
(H&E) with Luxol fast blue (LFB) (Figure 3A and 4) was 
the main staining method. We also created combined 
stains (Bielschowsky silver stain with LFB (Figure 3B) 
and neurofilament with LFB (Figure 3C), performed 
on the left frontal lesion to highlight the SCUF, to 
examine the axonal process, and to assess the myelin 
in relation to the axons.
With the aid of the pathological staging of CNS 
demyelination, we found that the left frontal lesion 
histologically showed an ill-defined area of late active 
plaque associated with alternating bands of preserved 
and non-preserved myelin in wavy patterns. Both 
bands showed preserved axons by neurofilament 
stain (Figure 3C). The right frontal lesion showed an 
ill-defined area of late active plaque with a deep loss of 
myelin (Figure 4). LFB stain showed spared SCUF in both 
lesions. Both frontal lesions showed typical features 
of demyelination with few macrophage-engulfed 
Figure 1. Brain MRI (T1 weighted images with contrast) shows a space-occupying lesion in the left frontal white 
matter, surrounded by mild edema. The lesion has a concentric onion-skin-like pattern (A - sagittal plane and B axial 
plane).
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myelin in the main plaque center, scant perivascular 
lymphocytic cuffs, few macrophages, and gliosis.
There were no features of acute ischemia in the 
affected areas. Periodic acid-Schiff (PAS) stain showed 
no evidence of specific variants of leukodystrophies. 
The optic nerve, optic chiasm, brainstem, spinal cord, 
and cerebellum were unremarkable. Ultrastructural 
examination of poorly preserved fixed tissue only 
Figure 2. A - Gross section of the right frontal lobe showing a brown-gray lesion; B and C - Gross examination of 
brain slices showing symmetrical brown-gray discolorations of the centrum semiovale extending into the digitate 
white matter (red arrow).
Figure 3. Histological sections of the left frontal lesion treated with different stains. A - H&E and LFB (10X); 
B - Bielschowsky with LFB (10X); C - Neurofilament with LFB (10X). The lesion shows a concentric pattern of 
myelinated and non-myelinated layers with spared subcortical U-fibers. The neurofilament shows intact axons.
Autopsy and Case Reports 2016;6(4):21-26
Balo’s concentric lesions with concurrent features of Schilder’s disease in relapsing multiple sclerosis: neuropathological findings
24
showed scattered myeloid and zebra bodies (Figure 5). 
The myelin was degenerated and the axons were 
somewhat preserved.
DISCUSSION
Atypical inflammatory demyelinating syndromes 
are rare neurological diseases that differ from MS, owing 
to unusual clinicoradiological or pathological findings, 
and poor responses to treatments.1 These syndromes 
include neuromyelitis optica, acute disseminated 
encephalomyelitis, tumefactive demyelination, Balo’s 
concentric sclerosis (BCS), Schilder’s disease (SD), and 
Marburg’s MS. If patients present with atypical MRI 
findings, atypical presentation, or do not respond 
well to the treatment that is usually effective for 
MS, these syndromes should be considered. Because 
some of these syndromes are associated with MS, 
the overlapping features are poorly defined, and may 
complicate the diagnosis.
Our patient had a 7-year history of chronic MS. 
She recently relapsed with newly acute symmetrical 
demyelinating lesions of the frontal lobe. The left 
frontal lesion showed Balo’s pattern while the right 
frontal lesion showed demyelination with spared SCUF.
BCS was described in 1928 by a Hungarian 
neuropathologist: Josef Bal.2 It characteristically occurs 
as a discrete concentrically layered lesion in the cerebral 
white matter.2 This distinctive appearance helps to 
distinguish it from other demyelinating lesions of 
conventional MS. The average age of onset of BCS is 
34 years and seems to be more common in patients 
of East Asian origin.3 BCS may occur simultaneously 
with MS-like lesions or may herald the onset of MS, 
indicating that, in certain patients, they seem to be 
different manifestations of the same disease rather 
than separate pathological entities.4 It can occur with 
anti-AQP4 antibody seropositive and seronegative 
neuromyelitis optica.5 On brain MRI, the lesion appears 
as concentric rings with alternating high and low 
Figure 4. Histological section of the right frontal lesion 
treated with H&E and LFB (10X) shows the gradual loss 
of myelin in deep white matter, which is associated with 
spared subcortical U-fibers (arrow).
Figure 5. Ultrastructural examination of the lesion by electron microscopy. A - Myeloid bodies; B - Zebra bodies. 
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intensity with minimal surrounding edema. It can be 
multiple at onset or occur as solitary lesions.6 Not all 
patients with BCS have oligoclonal bands: in a study 
of 11 patients with BCS, CSF synthesis of oligoclonal 
bands was present in one patient only.7
Pathologically, Balo’s lesions are well described 
and classically consist of cerebral white matter 
oligodendrocytes loss and demyelination, with 
sparing of the cortical grey matter.8 The lesions have 
an alternating ring appearance of relative myelin 
preservation and loss with relative axonal sparing, 
which gives them a so-called onion bulb appearance.9 
Astrocytopathy has been proposed as a hallmark 
feature of BCS.8
Several hypotheses have been proposed to explain 
the pathogenesis of the concentric lesions. The lesions 
seem to arise around a perivenular zone in response 
to an unknown stimulus that causes macrophages and 
activated microglia to produce cytokines and oxygen 
free radicals, which are responsible for inducing 
demyelination.10 Hypoxia inducible factor 1α might 
give a degree of neuroprotection to preserve the myelin 
between the rings of demyelination. Astrocyte AQP4 
and connexin are markedly reduced in these areas.11
In our patient’s case, the left frontal lesion showed 
features of BCS with preserved SCUF. The right frontal 
lesion showed a leukodystrophy-like pattern that 
involved the centrum semiovale to the digitate of white 
matter. These features can be seen in Schilder’s variant.
SD, also known as myelinoclastic diffuse sclerosis, 
was first described by Schilder in 1912.12 It is a sporadic 
atypical demyelinating brain disease that usually affects 
children. However, It can also occur in the third and 
fourth decades of life and appears to respond to 
vigorous treatment with corticosteroids. This rare 
disease results in formation of one or two bilateral 
large tumefactive plaques.13 In 1986, Poser et al.13 
established diagnostic criteria for the non-invasive 
diagnosis of SD. These criteria can be summarized as 
follows: (i) clinical symptoms and signs atypical for an 
early course of MS; (ii) a normal CSF, or atypical for MS; 
(iii) one or two symmetrical bilateral plaques measuring 
at least 3 × 2 cm and involving the centrum semiovale 
of the cerebral hemispheres; (iv) no fever, viral or 
mycoplasmal infection, or vaccination preceding the 
symptomatology; and (v) a normal serum concentration 
of very long-chain fatty acids. Additionally, it was 
noted that in SDs, CSF-restricted oligoclonal bands 
are generally absent, and that large bilateral areas of 
demyelination were mandatory for the diagnosis.14 
Some cases of SD represent adrenoleukodystrophy or 
“transitional” cases with MS. Adrenoleukodystrophy 
has been ruled out through clinical presentation, 
biochemical tests, and PAS.
The distinction between BCS and SD is summarized 
in Table 1.
Table 1. The distinction between Balo concentric sclerosis (BCS) and Schilder’s disease (SD)
BCS SD
Age and ethnicity Middle aged, East Asian Children or early young – any ethnicity
Location Cerebral white matter Cerebral white matter (semiovale)
Presentation Monophasic or with MS Monophasic or with MS
CSF-anti-AQP4 antibody Can be positive Negative
CSF-oligoclonal band IgG Negative Negative
VLCFA Normal Normal
Multiplicity Always solitary Always multiple
Symmetry Usually asymmetrical Usually symmetrical
Pathology Concentricity Concentricity can be present
Subcortical U-fibers Never spared Spared
Astrogliosis Dense Mild
Response to treatment None None
Outcome Poor Poor
AQP4 = aquaporin 4; CSF = cerebral spinal fluid; IgG = immunoglobulin G; MS = multiple sclerosis; VLCFA = very 
long-chain fatty acid.
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CONCLUSIONS
Atypical inflammatory demyelinating syndromes 
are rare neurologica l  d iseases with unusual 
clinicoradiological and pathological findings. BCS 
and SD are rare variants of this spectrum, which can 
occur simultaneously with MS. They are difficult to 
distinguish when they present at acute stages. The 
possible theory for our patient’s case was that the 
decedent’s MS was inactive for years then suddenly 
relapsed with atypical Balo’s lesions that asymmetrically 
progressed to Schilder’s pattern.
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